# Updates

Regular updates related to sourcing and the management of health products are available on this page.

40 items

- [Opportunity for Evaluation of Finished Pharmaceutical Products Lenacapavir for Pre-Exposure Prophylaxis](https://www.theglobalfund.org/en/sourcing-management/updates/2026-04-07-opportunity-evaluation-finished-pharmaceutical-products-lenacapavir-pre-exposure-prophylaxis/) (2026-04-07)
- [Opportunity for Evaluation of Pharmaceutical Products – Antituberculosis Medicines](https://www.theglobalfund.org/en/sourcing-management/updates/2026-03-10-opportunity-evaluation-pharmaceutical-products-antituberculosis-medicines/) (2026-03-10)
- [Opportunity for Evaluation of Pharmaceutical Products – Antituberculosis Medicines](https://www.theglobalfund.org/en/sourcing-management/updates/2025-07-15-opportunity-evaluation-pharmaceutical-products-antituberculosis-medicines/) (2025-07-15)
- [TB Ag Skin test (Cy-Tb) for Mycobacterium tuberculosis infection diagnosis manufactured by Serum Institute of India Pvt. Ltd. (SIIPL) recently recommended for use by Expert Review Panel](https://www.theglobalfund.org/en/sourcing-management/updates/2024-08-13-tb-ag-skin-test-mycobacterium-tuberculosis-infection-diagnosis-erp-recommendation/) (2024-08-13)
- [Opportunity for Evaluation of Pharmaceutical Products – Antituberculosis Medicines](https://www.theglobalfund.org/en/sourcing-management/updates/2024-07-15-opportunity-for-evaluation-of-pharmaceutical-products-antituberculosis-medicines/) (2024-07-15)
- [New Quality Assurance Policy on Vector Control Products and Related Equipment](https://www.theglobalfund.org/en/sourcing-management/updates/2024-04-24-quality-assurance-policy-vector-control-products-related-equipment/) (2024-04-24)
- [Post-market surveillance of insecticide-treated nets](https://www.theglobalfund.org/en/sourcing-management/updates/2024-04-16-post-market-surveillance-insecticide-treated-nets/) (2024-04-16)
- [Opportunity for Evaluation of Pharmaceutical Products – Antituberculosis Medicines](https://www.theglobalfund.org/en/sourcing-management/updates/2024-02-12-evaluation-pharmaceutical-products-antituberculosis-medicines/) (2024-02-12)
- [Revised Quality Assurance Policies for Pharmaceuticals and Medical Devices (including In Vitro Diagnostics) and Core Personal Protective Equipment](https://www.theglobalfund.org/en/sourcing-management/updates/2024-01-24-revised-quality-assurance-policies-pharmaceuticals-medical-devices-core-personal-protective-equipment/) (2024-01-24)
- [Update to Evaluation of Diagnostic Products – African-Manufactured HIV Rapid Tests](https://www.theglobalfund.org/en/sourcing-management/updates/2023-11-21-update-to-evaluation-of-diagnostic-products-african-manufactured-hiv-rapid-tests/) (2023-11-21)
- [Opportunity for Evaluation of Diagnostic Products - Malaria Rapid Diagnostic Tests](https://www.theglobalfund.org/en/sourcing-management/updates/2023-05-22-opportunity-for-evaluation-of-diagnostic-products-malaria-rapid-diagnostic-tests/) (2023-05-22)
- [Opportunity for Evaluation of Diagnostic Products](https://www.theglobalfund.org/en/sourcing-management/updates/2022-10-19-opportunity-for-evaluation-of-diagnostic-products/) (2022-10-19)
- [Placing Orders and Procuring Health Products for 2023](https://www.theglobalfund.org/en/sourcing-management/updates/2022-07-18-placing-orders-and-procuring-health-products-for-2023/) (2022-07-18)
- [Opportunity for Evaluation of Diagnostic Products – Syphilis Diagnosis](https://www.theglobalfund.org/en/sourcing-management/updates/2022-06-13-opportunity-for-evaluation-of-diagnostic-products-syphilis-diagnosis/) (2022-06-13)
- [New Isoniazid/rifapentine and rifapentine generic for tuberculosis (TB) prevention recently recommended for use by ERP](https://www.theglobalfund.org/en/sourcing-management/updates/2022-05-20-new-isoniazid-rifapentine-rifapentine-generic-tuberculosis-prevention-recently-recommended-erp/) (2022-05-20)
- [Opportunity for Evaluation of Diagnostic Products](https://www.theglobalfund.org/en/sourcing-management/updates/2022-04-08-opportunity-for-evaluation-of-diagnostic-products/) (2022-04-08)
- [Global Health Supply Chain Dialogue](https://www.theglobalfund.org/en/sourcing-management/updates/2022-03-17-global-health-supply-chain-dialogue/) (2022-03-17)
- [Misleading CE Mark Documentation Certification Issued by Real Companies](https://www.theglobalfund.org/en/sourcing-management/updates/2022-03-10-misleading-ce-mark-documentation-certification-issued-by-real-companies/) (2022-03-10)
- [Recalling US FDA Safety Communication on Pulse Oximeter Accuracy and Limitations](https://www.theglobalfund.org/en/sourcing-management/updates/2022-02-18-recalling-us-fda-safety-communication-on-pulse-oximeter-accuracy-and-limitations/) (2022-02-18)
- [The Supply Chain Roadmap](https://www.theglobalfund.org/en/sourcing-management/updates/2021-12-02-the-supply-chain-roadmap/) (2021-12-02)

[See all](https://www.theglobalfund.org/en/sourcing-management/updates/)
